Viewing StudyNCT00051493



Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00051493
Status: COMPLETED
Last Update Posted: 2006-07-19
First Post: 2003-01-10

Brief Title: ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer A Phase 2 Clinical Trial
Sponsor: Eli Lilly and Company
Organization: Eli Lilly and Company

Conditions & Keywords Data

Conditions:
Name
Carcinoma Non-Small-Cell Lung
Keywords:
Name View
Advanced Non-Small Cell Lung Cancer View
Non-Small Cell Lung Cancer View
Lung Cancer View
NSCLC View